Comparative cerebrospinal fluid diffusion of imipenem and meropenem in rats. 2000

A Dupuis, and A Caillaud, and C Pariat, and P Courtois, and W Couet, and S Bouquet
UPRES-EA 1223, Faculté de Medecine & Pharmacie and tLaboratoire de Pharmacocinétique, CHU la Milétrie, Poitiers, France.

The main objective of this study was to compare the cerebrospinal fluid (CSF) diffusion of imipenem and meropenem at steady state, following intravenous infusions at various rates in rats. A preliminary experiment was conducted to estimate the elimination half-lives of these two carbapenem antibiotics, and then to evaluate the infusion duration necessary to reach steady state. CSF diffusion of imipenem was essentially linear over the wide range of infusion rates (66-1,320microg min(-1)) and corresponding steady-state plasma concentrations (11.7-443.0 microg mL(-1)). Conversely the CSF diffusion of meropenem was saturable, with a predicted maximum CSF concentration equal to 1.3 microg mL(-1). Extrapolation of these data to the clinical situation may not be possible since the rats had normal blood-brain and blood-CSF barriers whereas patients with diseases such as meningitis may not. However, it is suggested that the observed differences in the diffusion characteristics of imipenem and meropenem may be partly responsible for their differences in toxicity and efficacy at the central level.

UI MeSH Term Description Entries
D008297 Male Males
D004058 Diffusion The tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space. Diffusion, especially FACILITATED DIFFUSION, is a major mechanism of BIOLOGICAL TRANSPORT. Diffusions
D000077731 Meropenem A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients. 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid,Merrem,Penem,Ronem,SM 7338,SM-7338,SM7338
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013845 Thienamycins Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors. Antibiotics, Thienamycin,Thienamycin Antibiotics
D015378 Imipenem Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor. Imipemide,N-Formimidoylthienamycin,Imipenem Anhydrous,Imipenem, Anhydrous,MK-0787,MK0787,Anhydrous Imipenem,Anhydrous, Imipenem,MK 0787,N Formimidoylthienamycin
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

A Dupuis, and A Caillaud, and C Pariat, and P Courtois, and W Couet, and S Bouquet
June 2020, Medecine et maladies infectieuses,
A Dupuis, and A Caillaud, and C Pariat, and P Courtois, and W Couet, and S Bouquet
January 2000, Fundamental & clinical pharmacology,
A Dupuis, and A Caillaud, and C Pariat, and P Courtois, and W Couet, and S Bouquet
May 1991, Pathologie-biologie,
A Dupuis, and A Caillaud, and C Pariat, and P Courtois, and W Couet, and S Bouquet
August 1995, The Journal of antimicrobial chemotherapy,
A Dupuis, and A Caillaud, and C Pariat, and P Courtois, and W Couet, and S Bouquet
April 1996, Antimicrobial agents and chemotherapy,
A Dupuis, and A Caillaud, and C Pariat, and P Courtois, and W Couet, and S Bouquet
January 1996, Antimicrobial agents and chemotherapy,
A Dupuis, and A Caillaud, and C Pariat, and P Courtois, and W Couet, and S Bouquet
March 2003, Ugeskrift for laeger,
A Dupuis, and A Caillaud, and C Pariat, and P Courtois, and W Couet, and S Bouquet
January 1959, Antibiotic medicine & clinical therapy (New York, NY),
A Dupuis, and A Caillaud, and C Pariat, and P Courtois, and W Couet, and S Bouquet
September 1997, Enfermedades infecciosas y microbiologia clinica,
Copied contents to your clipboard!